Skip to main content
MedPathMedPath Home
Clinical Trials/JPRN-jRCT1080222005
JPRN-jRCT1080222005
Unknown
N/A

Investigation of the clinical safety and efficacy of iguratimod in patients with rheumatoid arthritis

Eisai Co., Ltd.0 sites2,000 target enrollmentJanuary 23, 2013
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsRheumatoid Arthritis

Overview

Phase
N/A
Intervention
Not specified
Conditions
Rheumatoid Arthritis
Sponsor
Eisai Co., Ltd.
Enrollment
2000
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 23, 2013
End Date
TBD
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • •Patients with rheumatoid arthritis
  • •All patients who take iguratimod

Exclusion Criteria

  • •Pregnant women or women suspected of being pregnant
  • •Patients with a serious liver disorder
  • •Patients with peptic ulcer
  • •Patients with known hypersensitivity to iguratimod or any of its excipients

Outcomes

Primary Outcomes

Not specified

Similar Trials

Unknown
N/A
Investigation of the clinical safety and efficacy of iguratimod in patients with rheumatoid arthritisRheumatoid Arthritis
JPRN-jRCT1080222730Toyama Chemical Co., Ltd. (Current FUJIFILM Toyama Chemical Co., Ltd.)2,000
Not Yet Recruiting
N/A
Investigation of the clinical safety and efficacy of favipiravir (Avigan tablets) in patients with novel or re-emerging influenza virus infections
JPRN-jRCT1080223849FUJIFILM Toyama Chemical Co., Ltd. (Former Toyama Chemical Co., Ltd.)
Completed
N/A
Investigation of the Clinical Safety and Efficacy of Long-term Treatment With Fycompa Tablets in Adolescence Epilepsy Patients With Partial-onset Seizures (With or Without Secondary Generalized Seizures) or Primary Generalized Tonic-clonic Seizures
JPRN-jRCT1080224672Eisai Co., Ltd.500
Completed
N/A
Investigation of the Clinical Safety and Efficacy of Long-term Treatment With Fycompa Tablets in Adult Epilepsy Patients With Partial-onset Seizures (With or Without Secondary Generalized Seizures) or Primary Generalized Tonic-clonic Seizures
JPRN-jRCT1080224671Eisai Co., Ltd.3,750
Withdrawn
N/A
Clinical investigation of the safety and efficacy of ALIMAXX-B biliary stent for bile duct obstructioCBD obstructionmalignant biliary obstruction10018008
NL-OMON31943Alveolus, Inc.10